Christopher Peetz
2021
In 2021, Christopher Peetz earned a total compensation of $4.1M as President and Chief Executive Officer at Mirum Pharmaceuticals, a 38% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $412,500 |
|---|---|
| Option Awards | $2,546,950 |
| Salary | $600,000 |
| Stock Awards | $559,781 |
| Other | $11,600 |
| Total | $4,130,831 |
Peetz received $2.5M in option awards, accounting for 62% of the total pay in 2021.
Peetz also received $412.5K in non-equity incentive plan, $600K in salary, $559.8K in stock awards and $11.6K in other compensation.
Rankings
In 2021, Christopher Peetz's compensation ranked 3,237th out of 12,415 executives tracked by ExecPay. In other words, Peetz earned more than 73.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,237 out of 12,415 | 74th |
Division Manufacturing | 1,314 out of 5,508 | 76th |
Major group Chemicals And Allied Products | 534 out of 2,378 | 78th |
Industry group Drugs | 474 out of 2,099 | 77th |
Industry Pharmaceutical Preparations | 327 out of 1,549 | 79th |
Source: SEC filing on April 22, 2022.
Peetz's colleagues
We found three more compensation records of executives who worked with Christopher Peetz at Mirum Pharmaceuticals in 2021.
News
Mirum Pharmaceuticals CEO Christopher Peetz's 2023 pay jumps 47% to $6.5M
April 23, 2024
Mirum Pharmaceuticals CEO Christopher Peetz's 2022 pay rises 7% to $4.4M
May 1, 2023
Mirum Pharmaceuticals CEO Christopher Peetz's 2021 pay jumps 38% to $4.1M
April 22, 2022
Mirum Pharmaceuticals CEO Christopher Peetz's 2020 pay falls 52% to $3M
April 14, 2021